<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>phytochemical therapeutics &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/phytochemical-therapeutics/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 30 Nov 2025 08:44:28 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>phytochemical therapeutics &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>[6]-Shogaol Inhibits SARS-CoV-2 3CLpro Activity</title>
		<link>https://bioengineer.org/6-shogaol-inhibits-sars-cov-2-3clpro-activity/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 30 Nov 2025 08:44:24 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[COVID-19 drug development]]></category>
		<category><![CDATA[natural antiviral compounds]]></category>
		<category><![CDATA[phytochemical therapeutics]]></category>
		<category><![CDATA[SARS-CoV-2 3CLpro inhibition]]></category>
		<category><![CDATA[[6]-shogaol]]></category>
		<guid isPermaLink="false">https://bioengineer.org/6-shogaol-inhibits-sars-cov-2-3clpro-activity/</guid>

					<description><![CDATA[In the ongoing battle against the COVID-19 pandemic, researchers continue to explore novel approaches and compounds that may offer therapeutic benefits. A recent investigation into the inhibitory effects of [6]-shogaol, a bioactive compound derived from ginger, has shown promising results against the SARS-CoV-2 virus, specifically through the inhibition of the 3CLpro enzyme, a crucial target [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">303583</post-id>	</item>
	</channel>
</rss>
